Our present study indicates that the TGF-β2-TGFβR pathway adds to the mix, or network, of pathways driving growth in these HNSCC cell lines and may also function as a TKI-inducible resistance mechanism, although this will require extensive in vivo testing with xenografts in mice. Here, TGFB2 is linked to head and neck squamous cell carcinoma.